Cooper Companies | COO - Ebitda

Prezzo Delle Azioni
71.09
Cambio Giornaliero
1.17 1.67%
Mensile
-13.24%
Annuale
-11.04%
Q1 Previsione
67.81




Ebitda Cambiamento Data
Abbott USD 3.09B 44M 2025-09
Align Technology USD 183.84M 19.77M 2025-09
AtriCure USD 19.86M 2.06M 2025-12
Avanos Medical USD 10M 73.9M 2025-09
Bausch Health Companies USD 986M 74M 2025-09
Baxter International USD 426M 36M 2025-09
Bayer EUR 1.97B 457M 2025-12
Becton, Dickinson and Co. USD 1.71B 433M 2025-12
Boston Scientific USD 1.37B 1000K 2025-09
Cooper Companies USD 323.4M 13.2M 2025-12
Dentsply International USD 135M 32M 2025-12
Dexcom USD 422.2M 53.8M 2025-12
Edwards Lifesciences USD 464.3M 4.7M 2025-09
Globus Medical USD 280.46M 27.86M 2025-12
Haemonetics USD 115.53M 9.22M 2025-09
Hologic USD 330.4M 16.6M 2025-12
Insulet USD 194M 34M 2025-12
Integra LifeSciences USD 104.21M 25.76M 2025-12
Intuitive Surgical USD 919.7M 21M 2025-09
J&J USD 9.52B 389M 2025-09
Medtronic USD 2.93B 482M 2025-12
Merit Medical Systems USD 97.23M 17.69M 2025-12
Novartis USD 5.84B 235M 2025-09
ResMed USD 547.48M 27.46M 2025-12
STAAR Surgical USD -159K 34.78M 2025-12
Steris USD 389.7M 22.5M 2025-09
Stryker USD 1.67B 206M 2025-09
Tandem Diabetes Care USD 32.9M 30.13M 2025-12
Teleflex USD -328.81M 536.43M 2025-09
Zimmer Biomet Holdings USD 759M 120.8M 2025-12